Dietary Fibre, Short-Chain Fatty Acids and Colon Cancer;Ballaststoffe, kurzkettige Fettsäuren und Kolonkarzinom

Aktuelle Ernahrungsmedizin

Volumn 22, Issue 6, 1997, Pages 321-326

  Scheppach, W ^a   Pascu, M E ^a   Richter, F ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0000909558     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Burkitt D. P.: Epidemiology of cancer of the colon and recturn. Cancer 1971; 28: 3-13
2. Burkitt D. P., A. R. P. Walker, N. S. Painter: Effect of dietary fibre on stools and transit times, and its role in the causation of disease. Lancet 2 (1972) 1408-1412
3. Cummings J. H., S. A. Bingham, K. W. Heaton, M. A. Eastwood: Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology 103 (1992) 1783-1789
4. Williams R. D., W. H. Olmsted: The effect of cellulose, hemicellulose and lignin on the weight of the stool: a contribution to the study of taxation in man. J. Nutr. 11 (1936) 433-449
5. Cummings J. H., E. R. Beatty, S. M. Kingman, S. A. Bingham, H. N. Englyst: Digestion and physiological properties of resistant starch in the human large bowel. Br. J. Nutr. 75 (1996) 733-747
6. Cummings J. H., G. T. Macfarlane: The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol. 70 (1991) 443-459
7. Scheppach W., H. Kasper: Anaerober Abbau von Kohlenhydraten im Kolon. Akt. Ernähr. 10 (1985) 145-147
8. Soergel K. H.: Colonic fermentation: metabolic and clinical implications. Clin. Investig. 72 (1994) 742-748
9. Scheppach W., H. P. Bartram, F. Richter: Role of short-chain fatty acids in the prevention of colorectal cancer. Eur. J. Cancer 31A (1995) 1077-1080
10. Hamilton S.-R.: The molecular genetics of colorectal neoplasia. Gastroenterology 105 (1993) 3-7
11. Vogelstein B., E. R. Fearon, S. R. Hamilton, S. E. Kern, A. C. Preisinger, M. Leppert, Y. Nakamura, R. White, A. M. M. Smits, J. L. Bos: Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319 (1988) 525-532
12. Potter J. D.: Reconciling the epidemiology, physiology, and molecular biology of colon cancer. J. Am. Med. Assoc. 268 (1992) 1573-1576
13. Lipkin M.: Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res. 48 (1988) 235-245
14. Velazquez O. C., H. M. Lederer, J. L. Rombeau: Butyrate and the colonocyte - implications for neoplasia. Dig. Dis. Sci. 41 (1996) 727-739
15. Janne P., Y. Carpentier, G. Willems: Colonic mucosal atrophy induced by a liquid elemental diet in rats. Am. J. Dig. Dis. 22 (1977) 808-812
16. Kripke S.-A., A.-D. Fox, J.-M. Berman, R.-G. Settle, J.-L Rombeau: Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. J. Parenter. Enter. Nutr. 13 (1989) 109-116
17. Scheppach W., P. Bartram, A. Richter, F. Richter, G. Dusel, H. Liepold, G. Hofstetter, J. Ruthlein, H. Kasper: Effect of short-chain fatty acids on the human colonic mucosa in vitro. J. Parenter. Enter. Nutr. 16 (1992) 43-48
18. Scheppach W., H. Sommer, T. Kirchner, G.-M. Paganelli, P. Bartram, S. Christl, F. Richter, G. Dusel, H. Kasper: Effect of butyrate on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103 (1992) 51-56
19. Scheppach W., J. G. Müller, F. Boxberger, G. Dusel, F. Richter, H.-P. Bartram, C.-E. Dempfle, H. Kasper: Histological changes of the colonic mucosa following irrigation with short-chain fatty acids. Eur. J. Gastroenterol. Hepatol. 9 (1997) 163-168
20. Velazquez O. C. D. Zhou, R. W. Seto, A. Jabbar, J. Choi, H. M. Lederer, J. L. Rombeau: In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: associated in vivo effects on c-fos and c-jun expression. J. Parenter. Enter. Nutr. 20 (1996) 243-250
21. Bartram H. P., W. Scheppach, H. Schmid, A. Hofmann, G. Dusel, F. Richter, A. Richter, H. Kasper: Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: Effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res. 53 (1993) 3283-3288
22. Kim Y. S., D. Tsao, B. Siddiqui, J. S. Whitehead, P. Arnstein, J. Bennett, J. Hicks: Effects of sodium butyrate and dimethylsulfoxide onbiochemical properties of human colon cancer cells. Cancer 45 (1980) 1185-1192
23. Augeron C., C. L. Laboisse: Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res. 44 (1984) 3961-3969
24. Whitehead R. H., G. P. Young, P. S. Bhatal: Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27 (1986) 1457-14
25. Gum J. R, W. K. Kam, J. C. Byrd, J. W. Hicks, M. H. Sleisenger, Y.S. Kim: Effects of sodium butyrate on human colonic adenocarcinoma cells. J. Biol. Chem. 262 (1987) 1092-1097
26. Gamet L., D. Daviaud, C. Denis-Pouxvie L, C. Remesy, J.-C. Murat: Effects of short chain fatty acids on growth and differentiation of the human colon cancer cell line HT29. Int. J. Cancer 52 (1992) 286-289
27. Richter F., A. Weimer, A. Stahl, A. Richter, W. Scheppach, H.-P. Bartram, H. Kasper: Divergent effects of short chain fatty acids on growth and differentiation of HT 29 colon cancer cells. Gastroenterology 110 (1996) A 583
28. Gibson P. R. I. Moeller, O. Kagelari, M. Folino, G. P. Young: Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. J. Gastroenterol. Hepatol. 7 (1992) 165-172
29. Young G. P., F. A. Macrae, P. R. Gibson, M. Alexeyeff, R. H. Whitehead: Brush border hydrolases in normal and neoplastic colonic epithelium. J. Gastroenterol. Hepatol. 7 (1992) 347-354
30. Niles R. M., S. A. Wilhelm, P. Thomas, N. Zamcheck: The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different stages of differentiation. Cancer Invest. 6 (1988) 39-45
31. Saini K. G. Steele, P. Thomas: Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate. Biochem. J. 272 (1990) 541-544
32. Deng G., G. Liu, L. Hu, J. R. Gum, Y. S. Kim: Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res. 52 (1992) 3378-3383
33. Wilson J. R., M. Weiser: Colonic cancer cell (HT29) adhesion to laminin is altered by differentiation: Adhesion may involve galactosyltransferase. Exp. Cell Res. 201 (1992) 330-334
34. Gibson P. R., O. Rosella, G. Rosella, G. P. Young: Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro. Gastroenterology 107 (1994) 410-419
35. Que F. G., G. J. Gores: Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 110 (1996) 1238-1243
36. Götz C., M. Montenarh: p53 and its implication in apoptosis. Int. J. Oncol. 6 (1995) 1129-1135
37. Sinicrope F. A., S. B. Ruan, K. R. Cleary, L C. Stephens, J. J. Lee, B. Levin: Bel-2 and p53 oncoprotein expression during colorectal tumorgenesis. Cancer Res. 55 (1995) 237-241
38. Hague A., A. M. Manning, K. A. Hanlon, L. I. Huschtscha, D. Hart. C. Paraskeva: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53 independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int. J. Cancer 55 (1993) 498-505
39. Hague A., D. J. E. Elder, D. J. Hicks, C. Paraskeva: Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J. Cancer 60 (1995) 400-406
40. Heerdt B. G., M. A. Houston, L. H. Augenlicht: Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 54 (1994) 3288-3294
41. Rapp U. R.: Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6 (1991) 495-500
42. McBain J. A., A. Eastman, D. L. Simmons, G. R. Pettit, G. C: Mueller: Phorbol ester augments butyrate-induced apoptosis of colon cancer cells. Int. J. Cancer 67 (1996) 715-723
43. Tsujii M., R. N. DuBois: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83 (1995) 493-501
44. Young G. P., P. R. Gibson: Butyrate and the human cancer cell In: Cummings J. H., J. L. Rombeau, T. Sakata (Hrsg.): Physiological and clinical aspects of short-chain fatty acids. Cambridge University Press, Cambridge/UK (1995) 319-335
45. Stoddart J. H., M. A. Lane, R. M. Niles: Sodium butyrate suppresses the transforming activity of an activated N-ras oncogene in human colon carcinoma cells. Exp. Cell Res. 184 (1989) 16-27
46. lck associated with butyrate-induced differentiation of human colon carcinoma cells. Oncogene Res. 5 (1989) 13-23
47. Taylor C. W., Y. S. Kim, K. E. Childress-Fields, L. C. Yeoman: Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines. Cancer Lett. 62 (1992) 95-105
48. Souleimani A., C. Asselin: Regulation of c-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2. Biochem. Biophys. Res. Comm. 193 (1993) 330-336
49. Velazquez O. C., D. Zhou, R. W. Seto, A. Jabbar, J. Choi H. M. Lederer, J. L. Rombeau: In vivo crypt surface hyperproliferation is decreased by butyrate and increased by deoxycholate in normal rat colon: Associated in vivo effects on c-fos and c-jun expression. J. Parenter. Enter. Nutr. 20 (1996) 243-250
50. Kruh J., L. Tichonicky, N. Defer: Effect of butyrate on gene expression. In: Binder J. H., J. H. Cummings, K. H. Soergel (Hrsg.): Short chain fatty acids. Kluwer, Dordrecht (1994) 135-147
51. Freeman H. J.: Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia. Gastroenterology 91 (1986) 596-602
52. Deschner E. E., J. F. Ruperto, J. R. Lupton, H. L. Newmark: Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorgenesis. Cancer Lett. 52 (1990) 79-82
53. McIntyre A., P. R. Gibson, G. P. Young: Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34 (1993) 386-391
54. Perrin P., E. Cassagnau, C. Burg, Y. Patty, F. Vavasseur, J. Harb, J. Le Pendu, J.-Y. Douillard, J.-P. Galmiche, F. Bornet, K. Meflah: An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosts. Gastroenterology 107 (1994) 1697-1708
55. Velazquez O. C., A. Jabbar, R. P. DeMatteo, J. L. Rombeau: Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice. Surgery 120 (1996) 440-448